Nucleic acid vaccine against the SARS-CoV-2 coronavirus

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11759516
APP PUB NO 20220401550A1
SERIAL NO

17819187

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to an immunogenic or vaccine composition against the 2019 novel coronavirus (SARS-CoV-2), comprising a nucleic acid construct encoding a SARS-CoV-2 coronavirus Spike (S) protein antigen or a fragment thereof comprising the receptor-binding domain, wherein the nucleic acid construct sequence is codon-optimized for expression in human.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUT PASTEURPARIS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Montagutelli, Xavier Paris, FR 4 3
Prot, Matthieu Paris, FR 4 3
Simon-Loriere, Etienne Paris, FR 11 10

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Mar 19, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 19, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 19, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00